Answers are grounded in this paper and cite their sources.
Providers, consumers, payers, and policy makers are awash in choices when it comes to medical decision making and need better evidence to inform their decisions. Large federal investments in comparative effectiveness research (CER) aim to fill this need. But how do we ensure the clinical utility of CER? Here, I define comparative effectiveness and clinical utility, outline metrics to evaluate clinical utility, and suggest methods for maximizing the clinical utility of CER for the various stakeholders.
No takes yet. Share an insight, caveat, or question.
Craig A. Umscheid (2010) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: